A multicenter, retrospective study was conducted enrolling consecutive patients undergoing bifurcation PCI between 2002 and 2006 in 22 Italian centers. Patients were divided in 2 groups: age ¡Ü 45 years, and age > 45 years. The primary end-point was long-term rate of major adverse cardiac events (MACE).
4,314 patients were included: 195 (4.5 % ) in the younger group, and 4119 (95.5 % ) in the older group. 30-day outcomes did not show significant differences in MACE rates, with 1.0 % in the ¡Ü 45 years group and 2.1 % in the > 45 years group (p = 0.439), with death in 0.5 % and 1.2 % (p = 0.388). At long-term follow-up (24.4 ¡À 15.1 months), younger patients showed similar rates of MACE, (12.8 % vs. 16.6 % , p = 0.161), myocardial infarction (3.1 % vs. 3.7 % , p = 0.633), target lesion revascularization (11.3 % vs. 12.5 % , p = 0.627), or stent thrombosis (1.5 % vs. 2.8 % , p = 0.294), despite an increased risk of death in older patients (1.0 % vs. 5.0 % , p = 0.012). Even at extensive multivariable analysis, younger patients still faced a similar risk of MACE (HR = 0.78 [0.48-1.27], p = 0.318).
Despite their low age, young patients undergoing PCI for bifurcation face a significant risk of early and late non-fatal adverse events. Thus, they should not be denied careful medical management and follow-up.